Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

Amedisys (AMED) delivered earnings and revenue surprises of 10.62% and 0%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

UnitedHealth Group and Amedisys agreed to extend the deadline to complete their $3.3 billion merger, after the Department of Justice moved to block the deal.

Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden ...

NEW YORK — The Justice Department is suing to block UnitedHealth Group's $3.3 billion purchase of Amedisys, citing concerns the combination would hinder access to home health and hospice ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...

UnitedHealth, Amedisys agree to sell clinics to get merger across finish line The divestiture will only go through if UnitedHealth and Amedisys complete their merger, which was first announced ...

Amedisys plans to divest a number of care centers to VitalCaring Group in advance of its planned merger with UnitedHealth Group later this year.

UnitedHealth Group wanted Amedisys all along. The Minnesota health care conglomerate made acquisition overtures to Amedisys, the Baton Rouge home health provider, as far back as 2021, according to ...